{"doi":"10.1016/j.clml.2019.07.199","title":"The Safety and Efficacy Administration of Pegfilgrastim on Days +1, +5, +7 versus Filgrastim Day 7 in Patients Post Autologous Stem Cell Transplant in a Developing Country","abstract":null,"journal":"Clinical Lymphoma Myeloma and Leukemia","year":2019,"id":685480,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1790885,"name":"Henry Idrobo","orcid":null,"position":1,"is_corresponding":false},{"id":1790886,"name":"Alvaro Guerrero","orcid":null,"position":2,"is_corresponding":false},{"id":1790887,"name":"Rigoberto Gomez","orcid":null,"position":3,"is_corresponding":false},{"id":1790888,"name":"Juan Lasso","orcid":null,"position":4,"is_corresponding":false},{"id":1790889,"name":"Marcela Urrego","orcid":null,"position":5,"is_corresponding":false},{"id":1790890,"name":"Jorgue Duque","orcid":null,"position":6,"is_corresponding":false},{"id":1790891,"name":"Monica Morales","orcid":null,"position":7,"is_corresponding":false},{"id":1790892,"name":"Juan Herrera","orcid":null,"position":8,"is_corresponding":false},{"id":1003923,"name":"Eider Moreno","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"The Safety and Efficacy Administration of Pegfilgrastim on Days +1, +5, +7 versus Filgrastim Day 7 in Patients Post Autologous Stem Cell Transplant in a Developing Country","abstract":null,"is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"21097893","pmcid":null,"openalex_id":"https://openalex.org/W2970706782","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.12838274,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":"https://www.elsevier.com/legal/tdmrep-license","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S2152265019309589?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S2152265019309589?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.clml.2019.07.199","host_type":"journal"}],"fields_of_study":["Neutropenia and Cancer Infections","Hematopoietic Stem Cell Transplantation","Central Venous Catheters and Hemodialysis"],"mesh_terms":[],"keywords":["Pegfilgrastim","Filgrastim","Medicine","Granulocyte colony-stimulating factor","Administration (probate law)","Oncology","Internal medicine","Chemotherapy"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Partnerships for the goals"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-18T16:45:29.635172Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}